Children are especially vulnerable to air pollution: we need data on transport emissions near schools.

Autor: Belch JJF; University of Dundee, Ninewells Hospital and Medical School, Dundee, UK., Elder A; NHS Fife, UK.; Royal College of Physicians of Edinburgh, Edinburgh, UK., Bartlett S; Royal Infirmary of Edinburgh, NHS Lothian, UK., Fardon T; Respiratory Specialist Delivery Group, Centre for Sustainable Delivery, NHS Scotland, UK., Flinn K; Scottish Public Services Ombudsman, UK.; RCPE Lay Committee, Royal College of Physicians of Edinburgh, UK., Hughes RC; Centre on Climate Change and Planetary Health Management Group, London School of Health and Tropical Medicine, London, UK.; Clean Air Fund, London, UK., Miller MR; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK., Newby D; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK., Quinn T; University of Glasgow, Glasgow, UK.; NHS Greater Glasgow, UK., Slater M; Aberdeen Royal Infirmary, NHS Grampian, UK.

Publikováno v: BMJ (Clinical research ed.) [BMJ] 2023 Nov 21; Vol. 383, pp. 2675. Date of Electronic Publication: 2023 Nov 21.

Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project

Autor: Rothenbacher, D, Rehm, M, Iacoviello, L, Costanzo, S, Tunstall-Pedoe, H, Belch, JJF, Soderberg, S, Hultdin, J, Salomaa, V, Jousilahti, P, Linneberg, A, Sans, S, Padro, T, Thorand, B, Meisinger, C, Kee, F, McKnight, AJ, Palosaari, T, Kuulasmaa, K, Waldeyer, C, Zeller, T, Blankenberg, S, Koenig, W, BiomarCaRE Consortium

Publikováno v: BMC Medicine
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
BMC Medicine, Vol 18, Iss 1, Pp 1-13 (2020)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Background: Chronic kidney disease has emerged as a strong cardiovascular risk factor, and in many current guidelines, it is already considered as a coronary heart disease (CHD) equivalent. Routinely, creatinine has been used as the main marker of re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::64eb10f9c21cded390b3c9b9e4875735
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1280

A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis

Autor: Kitas, GD, Nightingale, P, Armitage, J, Sattar, N, Belch, JJF, Symmons, DPM, Trace Ra Consortium

Objective: Rheumatoid arthritis (RA) is associated with increased cardiovascular event (CVE) risk. The impact of statins in RA is not established. We assessed whether atorvastatin is superior to placebo for the primary prevention of CVEs in RA patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::49d30395d9132ae01a5798f6a835bdab
https://eprints.whiterose.ac.uk/151365/1/Kitas_et_al-2019-Arthritis_&_Rheumatology.pdf

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease: European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement.

Autor: Belch JJF; The Institute of Cardiovascular Research, University of Dundee, Ninewells Hospital and Medical School, Ninewells Hospital, Dundee, UK. Electronic address: j.j.f.belch@dundee.ac.uk., Brodmann M; Division of Angiology, Medical University, Graz, Austria., Baumgartner I; Swiss Cardiovascular Centre, Division of Angiology, Bern University Hospital, University of Bern, Switzerland., Binder CJ; Department of Laboratory Medicine, Medical University of Vienna, Austria., Casula M; Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Italy; IRCCS MultiMedica, Milan, Italy., Heiss C; Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK; Surrey and Sussex Healthcare NHS Trust, East Surrey Hospital, Redhill, UK., Kahan T; Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Parini P; Department of Medicine and Department of Laboratory Medicine, Karolinska Institutet, And Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden., Poredos P; Department of Vascular Disease, University Medical Centre Ljubljana, Slovenia., Catapano AL; IRCCS MultiMedica, Milan, Italy; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Italy., Tokgözoğlu L; Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Publikováno v: Atherosclerosis [Atherosclerosis] 2021 Dec; Vol. 338, pp. 55-63. Date of Electronic Publication: 2021 Nov 08.

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease.

Autor: Belch JJF; The Institute of Cardiovascular Research, University of Dundee, Ninewells Hospital and Medical School, Ninewells Hospital, Dundee, UK., Brodmann M; Division of Angiology, Medical University, Graz, Austria., Baumgartner I; Swiss Cardiovascular Centre, Division of Angiology, Bern University Hospital, University of Bern, Switzerland., Binder CJ; Department of Laboratory Medicine, Medical University of Vienna, Austria., Casula M; Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Italy.; IRCCS MultiMedica, Milan, Italy., Heiss C; Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.; Surrey and Sussex Healthcare NHS Trust, East Surrey Hospital, Redhill, UK., Kahan T; Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Parini P; Department of Medicine and Department of Laboratory Medicine, Karolinska Institutet, and Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden., Poredos P; Department of Vascular Disease, University Medical Centre Ljubljana, Slovenia., Catapano AL; IRCCS MultiMedica, Milan, Italy.; Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Italy., Tokgözoğlu L; Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Publikováno v: VASA. Zeitschrift fur Gefasskrankheiten [Vasa] 2021 Nov; Vol. 50 (6), pp. 401-411.